Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1963 Jun;42(6):811–822. doi: 10.1172/JCI104773

TWO TYPES OF γ-MYELOMA PROTEINS, β2A-MYELOMA PROTEINS, γ1-MACROGLOBULINS, AND BENCE JONES PROTEINS IDENTIFIED BY TWO GROUPS OF COMMON ANTIGENIC DETERMINANTS

John L Fahey 1, Alan Solomon 1
PMCID: PMC289351  PMID: 16695905

Full text

PDF
811

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASKONAS B. A., FAHEY J. L. Enzymatically produced subunits of proteins formed by plasma cells in mice. II. beta2a-Myeloma protein and Bence Jones protein. J Exp Med. 1962 Mar 1;115:641–653. doi: 10.1084/jem.115.3.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DEUTSCH H. F., KRATOCHVIL C. H., REIF A. E. Immunochemical relation of Bence-Jones proteins to normal serum proteins. J Biol Chem. 1955 Sep;216(1):103–111. [PubMed] [Google Scholar]
  3. EDELMAN G. M., GALLY J. A. The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins. J Exp Med. 1962 Aug 1;116:207–227. doi: 10.1084/jem.116.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FAHEY J. L. Chromatographic studies of anomalous gamma-, beta2a-, and macroblobulins and normal gamma-globulins in myeloma and macroglobulinemic sera. J Biol Chem. 1962 Feb;237:440–445. [PubMed] [Google Scholar]
  5. Fahey J. L. HETEROGENEITY OF MYELOMA PROTEINS. J Clin Invest. 1963 Jan;42(1):111–123. doi: 10.1172/JCI104688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GOULIAN M., FAHEY J. L. Abnormalities in serum proteins and protein-bound hexose in Hodgkin's disease. J Lab Clin Med. 1961 Mar;57:408–419. [PubMed] [Google Scholar]
  7. HABICH H. Zur Antigenanalyse der Paraproteine bei Makroglobulinämien. Schweiz Med Wochenschr. 1953 Dec 26;83(52):1253–1256. [PubMed] [Google Scholar]
  8. HAUSCHKA T. S., KVEDAR B. J., GRINNELL S. T., AMOS D. B. Immunoselection of polyploids from predominantly diploid cell populations. Ann N Y Acad Sci. 1956 Mar 14;63(5):683–705. doi: 10.1111/j.1749-6632.1956.tb50886.x. [DOI] [PubMed] [Google Scholar]
  9. Hektoen L., Welker W. H. Immunological differences of crystalline Bence-Jones proteins. Biochem J. 1940 Apr;34(4):487–489. doi: 10.1042/bj0340487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. KANZOW U., SCHOLTAN W., MUTING A. Serologische Differenzierung von Makroglobulinämien. Klin Wochenschr. 1955 Nov 15;33(43-44):1043–1046. doi: 10.1007/BF01467949. [DOI] [PubMed] [Google Scholar]
  11. KORNGOLD L. Abnormal plasma components and their significance in disease. Ann N Y Acad Sci. 1961 Aug 31;94:110–130. doi: 10.1111/j.1749-6632.1961.tb35536.x. [DOI] [PubMed] [Google Scholar]
  12. KORNGOLD L., LIPARI R. Multiple-myeloma proteins. I. Immunological studies. Cancer. 1956 Jan-Feb;9(1):183–192. doi: 10.1002/1097-0142(195601/02)9:1<183::aid-cncr2820090119>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  13. KORNGOLD L., LIPARI R. Multiple-myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gammaglobulin and multiple-myeloma serum proteins. Cancer. 1956 Mar-Apr;9(2):262–272. doi: 10.1002/1097-0142(195603/04)9:2<262::aid-cncr2820090210>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  14. KORNGOLD L., VAN LEEUWEN G. Macroglobulinemia. I. The antigenic relationship of pathological macroglobulins to normal gamma-globulins. J Exp Med. 1957 Oct 1;106(4):467–476. doi: 10.1084/jem.106.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. KUNKEL H. G., SLATER R. J., GOOD R. A. Relation between certain myeloma proteins and normal gamma globulin. Proc Soc Exp Biol Med. 1951 Jan;76(1):190–193. doi: 10.3181/00379727-76-18432. [DOI] [PubMed] [Google Scholar]
  16. MIGITA S., PUTNAM F. W. Antigenic relationships of Bence Jones proteins, myeloma globulins, and normal human gama-globulin. J Exp Med. 1963 Jan 1;117:81–104. doi: 10.1084/jem.117.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MORTON J. I., DEUTSCH H. F. Human serum macroglobulins and dissociation units. II. Immunochemical properties. J Biol Chem. 1958 Apr;231(2):1119–1127. [PubMed] [Google Scholar]
  18. OLINS D. E., EDELMAN G. M. The antigenic structure of the polypeptide chains of human gamma-globulin. J Exp Med. 1962 Nov 1;116:635–651. doi: 10.1084/jem.116.5.635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. OSSERMAN E. F., LAWLOR D. Immunoelectrophoretic characterization of the serum and urinary proteins in plasma cell myeloma and Waldenstrom's macroglobulinemia. Ann N Y Acad Sci. 1961 Aug 31;94:93–109. doi: 10.1111/j.1749-6632.1961.tb35535.x. [DOI] [PubMed] [Google Scholar]
  20. POULIK M. D., EDELMAN G. M. Comparison of reduced alkylated derivatives of some myeloma globulins and Bence-Jones proteins. Nature. 1961 Sep 23;191:1274–1276. doi: 10.1038/1911274a0. [DOI] [PubMed] [Google Scholar]
  21. PUTNAM F. W., EASLEY C. W., LYNN L. T., RITCHIE A. E., PHELPS R. A. The heat precipitation of Bence-Jones proteins. I. Optimum conditions. Arch Biochem Biophys. 1959 Jul;83(1):115–130. doi: 10.1016/0003-9861(59)90016-5. [DOI] [PubMed] [Google Scholar]
  22. REISNER C. A., FRANKLIN E. C. Studies of mercaptoethanol-dissociated normal human 19 S gamma-globulin and pathologic macroglobulins from patients with macroglobulinemia. J Immunol. 1961 Dec;87:654–664. [PubMed] [Google Scholar]
  23. SLATER R. J., WARD S. M., KUNKEL H. G. Immunological relationships among the myeloma proteins. J Exp Med. 1955 Jan 1;101(1):85–108. doi: 10.1084/jem.101.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. SMITH E. L., BROWN D. M., MCFADDEN M. L., BUETTNER-JANUSCH V., JAGER B. V. Physical, chemical, and immunological studies on globulins from multiple myeloma. J Biol Chem. 1955 Oct;216(2):601–620. [PubMed] [Google Scholar]
  25. THIJE O. J. T. Urinary and serum proteins in myelomatosis. Acta Med Scand. 1956 Jan 25;153(4):253–269. doi: 10.1111/j.0954-6820.1955.tb18226.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES